Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression
Ebrahim Haroon, James R. Welle, Bobbi J. Woolwine, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 998-1007
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Jiezhong Chen, Luis Vitetta
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5214-5214
Open Access | Times Cited: 234
The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies
Wolfgang Marx, Amelia J. McGuinness, Tetyana Rocks, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 4158-4178
Closed Access | Times Cited: 227
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 117
Peripheral and central kynurenine pathway abnormalities in major depression
Elisabeth Paul, Lilly Schwieler, Sophie Erhardt, et al.
Brain Behavior and Immunity (2022) Vol. 101, pp. 136-145
Open Access | Times Cited: 79
Effect of immune activation on the kynurenine pathway and depression symptoms – A systematic review and meta-analysis
Charlotte Hunt, Thiago Macedo e Cordeiro, Robert Suchting, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 118, pp. 514-523
Open Access | Times Cited: 116
Biomarkers of Post-COVID Depression
Piotr Lorkiewicz, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4142-4142
Open Access | Times Cited: 90
Inflammatory Depression—Mechanisms and Non-Pharmacological Interventions
Klara Suneson, Jesper Lindahl, Simon Chamli Hårsmar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1640-1640
Open Access | Times Cited: 80
The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
Francesco Bartoli, Błażej Misiak, Tommaso Callovini, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 7, pp. 3419-3429
Closed Access | Times Cited: 75
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 68
The kynurenine pathway in major depression: What we know and where to next
Samara Brown, Xu‐Feng Huang, Kelly A. Newell
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 917-927
Closed Access | Times Cited: 67
Metabolomic changes in animal models of depression: a systematic analysis
Juncai Pu, Yiyun Liu, Siwen Gui, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7328-7336
Open Access | Times Cited: 64
Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms
Sophie Leclercq, Markus Schwarz, Nathalie M. Delzenne, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 64
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy
Qiong Sha, Zach Madaj, Sarah A. Keaton, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 63
Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
Katrien Skorobogatov, Livia De Picker, Robert Verkerk, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Emma I Kopra, Valeria Mondelli, Carmine M. Pariante, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 934-945
Open Access | Times Cited: 59
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation
Yuri Milaneschi, Kelly A. Allers, Aartjan T.F. Beekman, et al.
Brain Behavior and Immunity (2021) Vol. 97, pp. 167-175
Open Access | Times Cited: 59
Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
Mandakh Bekhbat, Michael T. Treadway, Jennifer C. Felger
Current topics in behavioral neurosciences (2022), pp. 397-419
Closed Access | Times Cited: 41
Tryptophan metabolites in depression: Modulation by gut microbiota
Iva Lukić, Sanja Ivković, Miloš Mitić, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 41
Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
Gislaine Z. Réus, Luana M. Manosso, João Quevedo, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105425-105425
Closed Access | Times Cited: 35
Pro-inflammatory cytokines in stress-induced depression: Novel insights into mechanisms and promising therapeutic strategies
Jun Chang, Tingcan Jiang, Xiaoqian Shan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110931-110931
Closed Access | Times Cited: 12
Omega-3 fatty acids for inflamed depression – A match/mismatch study
Klara Suneson, Gustav Söderberg Veibäck, Jesper Lindahl, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 192-201
Open Access | Times Cited: 8
Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression
Yena Lee, Rodrigo B. Mansur, Elisa Brietzke, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 631-639
Closed Access | Times Cited: 57
Brain-immune crosstalk in the treatment of major depressive disorder
Igor Branchi, S. Poggini, Lucile Capuron, et al.
European Neuropsychopharmacology (2020) Vol. 45, pp. 89-107
Open Access | Times Cited: 56
Altered gut microbial metabolites could mediate the effects of risk factors in Covid‐19
Jiezhong Chen, Sean Hall, Luis Vitetta
Reviews in Medical Virology (2021) Vol. 31, Iss. 5, pp. 1-13
Open Access | Times Cited: 52
The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes
Timothy B. Meier, Jonathan Savitz
Biological Psychiatry (2021) Vol. 91, Iss. 5, pp. 449-458
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top